5920
D. A. Klumpp et al. / Tetrahedron 62 (2006) 5915–5921
is added. After 6 h, the mixture is poured over ice, the
solution is neutralized with NaOH, and the products are
extracted into CHCl3. The organic extracts are then washed
with H2O, brine, and dried with MgSO4. Concentration in
vacuo provides the crude products, which are then purified
by recrystallization or column chromatography.
3.2.6. 4-(6-Benzhydryl-pyridin-2-yl)-benzoic acid methyl
1
ester (19). White solid, mp 81–85 ꢁC (CHCl3). H NMR
(500 MHz, CDCl3), d, ppm: 4.02 (s, 3H), 5.93 (s, 1H),
7.19–7.21 (m, 1H), 7.33–7.37 (m, 2H), 7.41–7.47 (m, 8H),
7.55–7.58 (m, 1H), 7.69–7.70 (m 2H), 8.18 (d, J¼7.7 Hz,
1H), 8.35 (d, J¼7.7 Hz, 1H), 8.84 (s, 1H). 13C NMR
(125 MHz, CDCl3), d, ppm: 52.3, 59.7, 118.2, 122.9,
126.7, 128.1, 128.5, 129.0, 129.6, 130.0, 130.7, 131.6,
137.4, 139.8, 143.3, 155.6, 162.9, 167.1. MS: 379 (M+),
378, 348, 302, 241, 165. HRMS: C26H21NO2, calcd
379.157229, found 379.157033.
3.1.2. Procedure for the reactions and functionalization
of hydrocarbons. In a 125 mL Parr autoclave (glass-lined
and flushed with dry Ar), 4-pyridinecarboxaldehyde
(1 mmol) and methylcyclohexane (1 mmol) dissolved in
5 mL CHCl3 and 3 mL CF3SO3H were added. The reactor
is sealed and pressurized with carbon monoxide to 750 psi.
After 12 h of stirring at 25 ꢁC, the reactor was depressurized
and its contents were poured into an ice-cold solution of
CH3OH and Na2CO3. Filtration and removal of the solvent
gave crude product (22), which was further purified by
column chromatography.
3.2.7. 2-Amino-3-benzhydryl-pyridine (20). White solid,
1
mp 133–135 ꢁC (CHCl3). H NMR (500 MHz, CDCl3), d,
ppm: 4.32 (s, 2H), 5.36 (s, 1H), 6.64 (dd, J¼5.0, 7.5 Hz),
6.92 (d, J¼7.1 Hz, 1H), 7.14 (d, J¼7.1 Hz, 4H), 7.14–7.36
(m, 6H), 8.03 (d, J¼4.0 Hz, 1H). 13C NMR (125 MHz,
CDCl3), d, ppm: 52.2, 114.5, 123.4, 127.1, 128.8, 129.4,
137.6, 141.3, 146.2, 156.6. MS: 260 (M+), 259, 242,
181, 165. HRMS: C18H16N2, calcd 260.131349, found
260.131390.
3.2. Analytical data for new compounds
3.2.1. 4,40-Dibenzhydryl-[2,20]bipyridinyl (14). Brown
solid, mp 181–187 ꢁC (CHCl3). 1H NMR (500 MHz,
CDCl3), d, ppm: 5.67 (s, 2H), 7.05 (d, J¼3.9 Hz, 2H),
7.18–7.37 (m, J¼20 Hz), 8.33 (s, 2H), 8.59 (d, J¼4.7 Hz,
2H). 13C NMR (125 MHz, CDCl3), d, ppm: 56.6, 122.4,
124.6, 126.8, 128.6, 129.4, 142.2, 149.3, 153.9. HRMS:
C36H28N2, calcd 488.225249, found 488.223488.
3.2.8. 3-Benzhydryl-1-methyl pyridinium triflate (21).
White solid, mp 131–133 ꢁC (Hexane–ether). 1H NMR
(CDCl3, 500 MHz), d, ppm: 4.36 (s, 3H), 5.85 (s, 1H), 7.12–
7.15 (m, 4H), 7.25–7.29 (m, 2H), 7.31–7.36 (m, 4H), 7.87
(dd, J¼6.1, 8.1 Hz, 1H), 8.05 (d, J¼8.2 Hz, 1H), 8.53 (s,
1H), 8.81 (d, J¼6.0 Hz, 1H). 13C NMR (CDCl3, 125 MHz),
d, ppm: 48.8, 53.4, 120.7 (q, JC–F¼320 Hz), 127.7, 129.2,
129.3, 140.0, 143.8, 145.0, 145.3, 146.0. Calcd: C, 58.67;
H, 4.43; N, 3.42; found: C, 58.63; H, 4.35; N, 3.40.
3.2.2. 2,6-Dibenzhydryl-pyridine (15). Yellow solid, mp
1
94–101 ꢁC (CHCl3). H NMR (500 MHz, CDCl3), d, ppm:
5.66 (s, 2H), 7.06 (d, J¼7.7 Hz, 2H), 7.28–7.35 (m, 20H),
7.57 (t, J¼7.7 Hz, 1H). 13C NMR (125 MHz, CDCl3), d,
ppm: 59.2, 121.4, 126.4, 128.3, 129.5, 136.9, 143.2, 162.4.
MS: 411 (M+), 410, 332, 244, 165. HRMS: C31H25N, calcd
411.198700, found 411.198941.
3.2.9. 1-Methyl-cyclohexanecarboxylic acid pyridin-4-yl-
methyl ester (22). Oil. 1H NMR (CDCl3, 500 MHz), d, ppm:
1.16 (s, 3H), 1.20–1.56 (m, 8H), 2.00–2.04 (m, 2H), 5.08 (s,
2H), 7.19–7.21 (m, 2H), 8.56 (s, 2H). 13C NMR (CDCl3,
125 MHz), d, ppm: 23.1, 25.6, 35.4, 43.2, 63.9, 121.8,
145.5, 149.8, 177.2. MS: 233 (M+), 178, 125, 97.
3.2.3. 3-Benzhydryl-5-bromo-pyridine (16). Oil. 1H NMR
(500 MHz, CDCl3), d, ppm: 5.60 (s, 1H), 7.16–7.18 (d,
J¼7.4 Hz, 2H), 7.28–7.41 (m, 6H), 7.63 (br s, 1H), 8.42
(d, J¼1.2 Hz, 1H), 8.62 (d, J¼1.8 Hz, 1H). 13C NMR
(125 MHz, CDCl3), d, ppm: 54.1, 120.8, 127.1, 128.8,
129.3, 139.2, 141.4, 142.0, 148.9, 149.1. MS: 325 (M+),
323, 244, 167. HRMS: C18H14BrN, calcd 323.030961, found
323.030937.
3.2.10. Adamantane-1-carboxylic acid pyridin-4-yl-
methyl ester (23). White solid, mp 55–56 ꢁC (hexane–
ether). 1H NMR (CDCl3, 500 MHz), d, ppm: 1.66–1.74
(m, 6H), 1.92 (s, 6H), 1.99–2.03 (m, 3H), 5.09 (s, 2H),
7.23 (d, J¼4.4 Hz, 2H), 8.57 (d, J¼3.5 Hz, 2H). 13C NMR
(CDCl3, 125 MHz), d, ppm: 27.9, 36.4, 38.8, 40.8,
63.7, 121.7, 146.1, 149.5, 176.9. MS: 271 (M+), 227, 163,
135, 93.
3.2.4. 2-Benzhydryl-6-methyl-pyridine (17). White solid,
mp 53–58 ꢁC (CHCl3). 1H NMR (500 MHz, CDCl3), d,
ppm: 2.63 (s, 1H), 5.91 (s, 1H), 6.97 (d, J¼7.7 Hz, 1H),
7.02 (d, J¼7.7 Hz, 1H), 7.27–7.38 (m, 10H), 7.48–7.51
(m, 1H). 13C NMR (125 MHz, CDCl3), d, ppm: 24.6, 59.5,
121.0, 121.3, 126.6, 128.5, 129.6, 136.9, 143.1, 158.0,
162.5. MS: 259 (M+), 258, 243, 181, 165. HRMS:
C19H17N, calcd 259.136100, found 259.136453.
Acknowledgements
The financial support of the NIH-NIGMS (GM071368-01
and SO6GM53933-0251), and Northern Illinois University
is greatly appreciated. Special thanks are also given to
Professor Elisheva Goldstein for guidance with the ab initio
calculations, and to the reviewers of this manuscript for their
comments.
3.2.5. 3-Benzhydryl-2-methoxy-pyridine (18). White
solid, mp 98–101 ꢁC (CHCl3). 1H NMR (500 MHz,
CDCl3), d, ppm: 3.94 (s, 3H), 5.85 (s, 1H), 6.86 (dd,
J¼7.3, 5.0 Hz, 1H), 7.10–7.38 (m, 11H), 8.13 (dd, J¼5.0,
1.9 Hz, 1H). 13C NMR (125 MHz, CDCl3), d, ppm:
49.7, 53.6, 116.6, 126.4, 126.9, 128.3, 128.8, 129.3, 138.5,
142.8, 144.7, 161.6. MS: 275 (M+), 260, 242, 184, 167.
HRMS: C19H17NO, calcd 275.131014, found 275.130983.
Supplementary data
Supplementary data associated with this article can be found